APD90 as a Predictor for Torsades de Pointes
While APD90 (action potential duration at 90% repolarization) is a valuable cellular-level metric that directly reflects repolarization prolongation, it is not clinically the "best" predictor for TdP—the QTc interval >500 ms combined with T-U wave distortion and increased dispersion of repolarization are superior clinical predictors.
Why APD90 Matters at the Cellular Level
APD90 represents the duration from action potential upstroke to 90% repolarization at the cellular level. This metric directly captures:
- Repolarization prolongation: The fundamental cellular abnormality underlying TdP 1
- Early afterdepolarization (EAD) substrate: Prolonged APD90 creates the conditions for EADs, which trigger TdP 1, 2
- Correlation with clinical outcomes: Studies demonstrate significant correlation between APD90 prolongation and TdP occurrence 2
In experimental models, APD90 at 90% repolarization was significantly longer in hearts developing TdP, and the dispersion of APD90 (variability across different cardiac regions) was markedly increased before arrhythmia onset 1.
The Critical Limitation: Dispersion Matters More Than Duration Alone
The key insight is that APD90 prolongation alone is insufficient—spatial dispersion of APD90 across the myocardium is the critical determinant 1, 2. In patients with TdP:
- Dispersion of APD90 and repolarization time was significantly greater than in controls 2
- Heterogeneous prolongation creates the substrate for reentrant circuits 3
- The short-long-short sequence further exaggerates this dispersion, triggering the arrhythmia 3
Clinical Translation: Why QTc and Morphology Supersede APD90
In clinical practice, we cannot directly measure APD90—we rely on surface ECG surrogates. The AHA/ACCF guidelines establish that 3:
- QTc >500 ms carries 2-3 fold increased TdP risk
- T-U wave distortion after pauses indicates dangerous dispersion
- Macroscopic T-wave alternans signals imminent arrhythmia
- LQT2-type repolarization patterns (notching, prolonged Tpeak-Tend) indicate high risk
These clinical markers integrate both duration AND dispersion information that APD90 alone cannot capture.
Recent Evidence on Action Potential Morphology
Emerging research suggests that action potential morphology analysis (measuring curvature and shape changes during repolarization) may outperform simple APD90 measurements for predicting TdP risk 4. This approach achieved 93.75% accuracy in classifying proarrhythmic drugs, superior to APD90 alone, because morphology captures:
- Triangulation of the action potential
- Regional heterogeneity
- Dynamic instability during repolarization
The Mechanistic Framework
APD90 prolongation creates TdP risk through this sequence:
- Ion channel blockade (typically IKr) prolongs APD90 3
- Heterogeneous prolongation creates dispersion across myocardial layers 3
- EADs emerge when APD90 is sufficiently prolonged, especially after pauses 1, 2
- Triggered activity from EADs initiates the first beat 1
- Reentry through regions of heterogeneous refractoriness maintains TdP 5
Clinical Bottom Line
For bedside risk assessment, monitor QTc with attention to morphology rather than seeking APD90 measurements. Specifically watch for 3:
- QTc exceeding 500 ms (or increase >60 ms from baseline)
- Exaggerated QT prolongation and T-U distortion after pauses
- New ventricular ectopy with short-long-short patterns
- Visible T-wave alternans
These integrated markers capture both the duration (reflected by APD90) and the critical dispersion component that APD90 alone misses. When these appear, immediately discontinue offending drugs, administer IV magnesium 2g, correct electrolytes (K+ to 4.5-5 mmol/L), and consider temporary pacing to prevent bradycardia 3.